CN103007237A - Medicine for treating idiopathic thrombocytopenic purpura (ITP) - Google Patents
Medicine for treating idiopathic thrombocytopenic purpura (ITP) Download PDFInfo
- Publication number
- CN103007237A CN103007237A CN201210595364XA CN201210595364A CN103007237A CN 103007237 A CN103007237 A CN 103007237A CN 201210595364X A CN201210595364X A CN 201210595364XA CN 201210595364 A CN201210595364 A CN 201210595364A CN 103007237 A CN103007237 A CN 103007237A
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- root
- itp
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating idiopathic thrombocytopenic purpura (ITP), aiming to screen natural Chinese herbal medicine components to enable the natural Chinese herbal medicine components to come into play according to the knowledge of pathogenesis of ITP in the traditional Chinese medicine and treatment rules of ITP. The medicine is prepared from the following components: 75g of cassia twig, 4g of asarum, 15g of prepared common monkshood branched root, 50g of fresh ginger, 75g of kelp, 10g of almonds, 150g of Chinese dates, 60g of turmeric root tuber, 50g of turmeric, 12g of saffron, 16g of ginkgo leaves, 18g of lightyellow sophora root, 15g of peony root, 10g of common hogfenneI root, 12g of calamus, 6g of storax, 30g of heartleaf houttuynia herb and 10g of white mulberry root-bark, wherein the medicines are ground into fine powder and are taken after being mixed with boiling water.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to the medicine for the treatment of idiopathic thrombocytopenic purpura, specifically the Chinese patent medicine of preparation take Chinese herbal medicine as raw material.
The background technology idiopathic thrombocytopenic purpura is the platelet autoimmune destruction, thrombocytopenic hemorrhage in the peripheral blood.With extensive skin, mucosa or visceral hemorrhage, thrombocytopenia, cause skin petechia ecchymosis, mucosa and visceral hemorrhage, severe patient can cause intracranial hemorrhage and threat to life, it is a kind of disease of serious harm health, at present western medical treatment should disease take hormone (such as glucocorticoid) as main, but the side effect of hormone is huge, can bring other serious complication (as occurring the disease such as hypoadrenocorticism behind the hormone of stopping using) to human body.This disease belongs to motherland's medical science " blood disorder " category, and therefore Chinese medicine tool aspect this disease for the treatment of is invented the medicine for the treatment of idiopathic thrombocytopenic purpura and treated this disease with huge potentiality.
Summary of the invention the purpose of this invention is to provide the medicine for the treatment of idiopathic thrombocytopenic purpura, to overcome the deficiencies in the prior art.
The objective of the invention is according to pathogenetic understanding and the Therapeutic Principle thereof of motherland's medical tradition medical science to idiopathic thrombocytopenic purpura, with reference to modern pharmacological research, therefrom filter out this sick natural Chinese medicinal herb for the treatment of, by the theory of Chinese medical science prescription, it is played a role.
Medicine of the present invention is made by following component:
Ramulus Cinnamomi 75 gram Herba Asaris 4 gram Radix Aconiti Lateralis Preparatas 15 gram Rhizoma Zingiberis Recenss 50 gram Thallus Laminariae (Thallus Eckloniae)s 75 gram Semen Armeniacae Amarums 10 gram Fructus Jujubaes 150 gram Radix Curcumaes 60 gram Rhizoma Curcumae Longaes 50 gram Stigma Crocis 12 gram Folium Ginkgos 16 gram Radix Sophorae Flavescentiss 18 gram Radix Paeoniae Rubra 15 gram Radix Peucedanis 10 gram Rhizoma Acori Gramineis 12 gram Styrax 6 gram Herba Houttuyniae 30 gram Cortex Mori 10 grams
Above-mentioned each component mix homogeneously is ground into 180 order fine powders, is distributed into bag, every packed medicated powder 9 grams.One after each meal, is used warm boiled water at twice at one bag of every day.
Medicine of the present invention is Chinese medicine preparation, and is theoretical according to traditional Chinese medical science prescription, select medicine rationally, treating both the principal and secondary aspects of a disease.Medicine of the present invention, through clinical observation patient for many years, evident in efficacy, the idiopathic thromboeytopenic purpura idiopathic thromboeytopenic purpura people that a variety of causes is caused has remarkable result.
Clinical drug of the present invention is taken the result and is shown, following advantage is arranged:
It is raw material that the present invention selects natural plant, and each component meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment idiopathic thrombocytopenic purpura of the medicine of respectively distinguishing the flavor of, nontoxic to human body without chemicals, has no side effect, safe and reliable.The present invention is powder, and effective ingredient scatters and disappears few, and curative effect is high, and cheap, taking convenience is without any discomfort disease.
For showing that medicine of the present invention is to the therapeutic effect of idiopathic thrombocytopenic purpura, the present invention is through the clinical observation of 540 routine idiopathic thrombocytopenic purpura patient systems, and select medical history, the state of an illness, age and the idiopathic thrombocytopenic purpura Patients with 300 Cases suitable with traditional therapy to organize as a comparison, age 16-62 year, course of disease 1-6; Test group: the conventional medicine of stopping using, take medicine of the present invention; Matched group: take conventional medicine.Observation period is 3 months, checks after half a year, and for produce effects, the state of an illness is clearly better as effectively without recurrence, and it is not obvious that sb.'s illness took a favorable turn is invalid.
Clinical experiment the results are shown in Table 1.
Table 1: take medicine of the present invention with the observation of curative effect of traditional Western medicine to idiopathic thrombocytopenic purpura.
Two groups of effective percentage of table 1 relatively
Annotate: curative effect relatively adopts statistical method, and enumeration data adopts X
2Check, two groups of effective percentage compare P<0.01
As can be seen from Table 1, two groups of effective percentage relatively: the experimental group total effective rate is 96.3%, and matched group is 40.6%, and experimental group obviously is better than matched group (P<0.01), illustrates that medication effect of the present invention significantly is better than traditional Western medicine.
The specific embodiment
Choose raw material by following proportioning:
Ramulus Cinnamomi 75 gram Herba Asaris 4 gram Radix Aconiti Lateralis Preparatas 15 gram Rhizoma Zingiberis Recenss 50 gram Thallus Laminariae (Thallus Eckloniae)s 75 gram Semen Armeniacae Amarums 10 gram Fructus Jujubaes 150 gram Radix Curcumaes 60 gram Rhizoma Curcumae Longaes 50 gram Stigma Crocis 12 gram Folium Ginkgos 16 gram Radix Sophorae Flavescentiss 18 gram Radix Paeoniae Rubra 15 gram Radix Peucedanis 10 gram Rhizoma Acori Gramineis 12 gram Styrax 6 gram Herba Houttuyniae 30 gram Cortex Mori 10 grams
Above-mentioned each component mix homogeneously is ground into 180 order fine powders, is distributed into bag, every packed medicated powder 9 grams.One after each meal, is used warm boiled water at twice at one bag of every day.
Claims (1)
1. the medicine for the treatment of idiopathic thrombocytopenic purpura is characterized in that the powder of being made by the raw material of following weight proportioning: Ramulus Cinnamomi 75 grams, Herba Asari 4 grams, Radix Aconiti Lateralis Preparata 15 grams, Rhizoma Zingiberis Recens 50 grams, Thallus Laminariae (Thallus Eckloniae) 75 grams, Semen Armeniacae Amarum 10 grams, Fructus Jujubae 150 grams, Radix Curcumae 60 grams, Rhizoma Curcumae Longae 50 grams, Stigma Croci 12 grams, Folium Ginkgo 16 grams, Radix Sophorae Flavescentis 18 grams, Radix Paeoniae Rubra 15 grams, Radix Peucedani 10 grams, Rhizoma Acori Graminei 12 grams, Styrax 6 grams, Herba Houttuyniae 30 grams, Cortex Mori 10 grams; Above-mentioned each component mix homogeneously is ground into 180 order fine powders and get final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210595364XA CN103007237B (en) | 2012-12-10 | 2012-12-10 | Medicine for treating idiopathic thrombocytopenic purpura (ITP) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210595364XA CN103007237B (en) | 2012-12-10 | 2012-12-10 | Medicine for treating idiopathic thrombocytopenic purpura (ITP) |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103007237A true CN103007237A (en) | 2013-04-03 |
CN103007237B CN103007237B (en) | 2013-12-04 |
Family
ID=47956701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210595364XA Expired - Fee Related CN103007237B (en) | 2012-12-10 | 2012-12-10 | Medicine for treating idiopathic thrombocytopenic purpura (ITP) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103007237B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106176948A (en) * | 2016-08-31 | 2016-12-07 | 高艳 | A kind of light-duty chronic purpura method for preparing externally applied of child |
CN106214750A (en) * | 2016-08-31 | 2016-12-14 | 青岛大学附属医院 | A kind of medicine for external use treating body surface internal hemorrhage |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101115493A (en) * | 2005-08-12 | 2008-01-30 | 河乃建仁 | Agent for hair growth |
-
2012
- 2012-12-10 CN CN201210595364XA patent/CN103007237B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101115493A (en) * | 2005-08-12 | 2008-01-30 | 河乃建仁 | Agent for hair growth |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106176948A (en) * | 2016-08-31 | 2016-12-07 | 高艳 | A kind of light-duty chronic purpura method for preparing externally applied of child |
CN106214750A (en) * | 2016-08-31 | 2016-12-14 | 青岛大学附属医院 | A kind of medicine for external use treating body surface internal hemorrhage |
Also Published As
Publication number | Publication date |
---|---|
CN103007237B (en) | 2013-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101708281B (en) | Chinese medicinal preparation for nourishing heart and tranquilizing mind and preparation method thereof | |
CN102133271B (en) | Medicinal tea for curing gout | |
CN103007237B (en) | Medicine for treating idiopathic thrombocytopenic purpura (ITP) | |
CN102526613B (en) | Medicament for treating allergic cutaneous vasculitis | |
CN104800799B (en) | It is a kind of to treat Chinese medicine of the endometrial thickness with ovarian cyst | |
CN102973803A (en) | Drug for treating hematopathy primary thrombocytopenic purpura | |
CN102526622B (en) | Medicine for treating knee-joint bursitis | |
CN102824460A (en) | Medicine for treating urticaria | |
CN103585471B (en) | Traditional Chinese medicine composition for treating thrombocytopenia | |
CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
CN102512589B (en) | Medicine for treating early sudden deafness | |
CN101979057A (en) | Medicine for treating anaphylactoid purpura and preparation method thereof | |
CN103301261A (en) | Medicine for treating transplant kidney main renal venous stenosis | |
CN102552569B (en) | Medicine for treating renal artery type arteritis | |
CN103690675A (en) | Traditional Chinese medicine composition detoxicating pills with effects of clearing away heat and toxic materials and improving immunity | |
CN102648975A (en) | Traditional Chinese medicine for treating primary thrombocytopenic purpura | |
CN103230484B (en) | Drug for treating knee osteoarthritis of patients under age of 40 | |
CN102406875A (en) | Drug for treating endometriosis interna | |
CN103990101A (en) | Traditional Chinese medicine composition for treating gynecological disease | |
CN103070992A (en) | Medicine for treating high myopia macular hemorrhages | |
CN102908598B (en) | Medicine for treating children fungal pneumonia | |
CN102512546B (en) | Traditional Chinese medicine used for esophageal cancer patients refusing surgery | |
CN102526610A (en) | Traditional Chinese medicine for curing multiple takayasu arteritis | |
CN102512637B (en) | Medicine for treating special chronic sinusitis of patients | |
CN102430095A (en) | Medicine for treating lung cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131204 Termination date: 20141210 |
|
EXPY | Termination of patent right or utility model |